Cachexia is a wasting syndrome characterized by weight loss. Cachexia is associated with chronic inflammatory conditions and cancer. It is a multifactorial syndrome characterized by loss of body weight, anorexia, anemia, and asthenia. It is more prevalent in patients with tumors of the lung, pancreas, and upper gastrointestinal tract as well as oral cancer patients. According to statistics, incidence of cachexia is high in developed regions such as North America, Europe, and Japan. Nearly 9 million individuals are affected by cachexia across the world. In the U.S., approximately 5 million individuals are affected by cachexia. The prevalence rate of cachexia varies from 5% to 15% in end-stage chronic heart failure to 50% to 80% in progressive cancer. The average mortality rate of cachexia for chronic obstructive pulmonary disease (COPD) is nearly 10% to 15%; 20% to 30% in individuals with chronic heart failure and chronic kidney disease, and approximately 80% in cancer patients.
The global oral cachexia nutrition supplementation market is driven by increase in incidence of chronic diseases such as cancer, chronic obstructive pulmonary disease, and tuberculosis among individuals, rise in health care expenditure in developing and developed countries, surge in awareness about nutritional supplements, and rise in product approvals. However; limited availability of products in certain parts of the globe, high cost, and risk of side effects if not administered adequately act as major restraints of the global market.
The global oral cachexia nutrition supplementation market can be segmented based on dosage form, indication, distribution channel, and region. In terms of dosage form, the market can be bifurcated into powder and liquid. Based on indication, the global oral cachexia nutrition supplementation market can be divided into chronic obstructive pulmonary disease (COPD), cancer, tuberculosis, AIDS, and others. In terms of distribution channel, the market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
The global oral cachexia nutrition supplementation market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to dominate the global market in terms of share during the forecast period. This is attributed to increase in incidence of chronic diseases, rise in health care expenditure, presence of major manufacturers, and surge in demand. Asia Pacific is anticipated to present lucrative opportunities in the oral cachexia nutrition supplementation market owing to increase in patient population, rise in awareness about nutritional supplements, surge in mergers & acquisitions, and improving health care infrastructure in developing countries. The market in Latin America and Middle East & Africa is expected to be driven by increase in spending capabilities, rise in investment in health care, favorable government support programs for spreading awareness, and adoption of expansion strategies by manufacturers in these regions through strategic collaborations with regional and local manufacturers & distributors to increase product availability.
Major players operating in the global oral cachexia nutrition supplementation market include Abbott Laboratories, Danone Nutricia, Nestle, Prodiet Clinical Nutrition, Mead Johnson & Company, LLC, and Other Prominent Players.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.